The Beijing-based American Chamber of Commerce said on Friday that companies in the pharmaceutical sector had reported that ...

Swiss pharmaceuticals powerhouse Roche says it plans to invest $50 billion in the United States over the next five years and ...

Takeda Pharmaceuticals, Japan's largest drugmaker, has undergone a sweeping transformation under CEO Christophe Weber, ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Pharmaceutical companies in China are reporting that they have been able to import some drugs over the past week with tariff ...

U.S. tariffs on pharmaceuticals could eventually mean higher prices for brand-name medicines, but in the near term the costs ...

The Trump administration is proceeding with probes into the national security implications of pharmaceutical imports.

A unique Novo Nordisk legal challenge to the Medicare drug pricing program could have big implications for the pharma ...

Exiger warns the U.S. is overly reliant on foreign countries to make key components of crucial medications as the Trump ...

With the potential for pharmaceutical import tariffs spurring a rush of life sciences investments in the U.S., AbbVie is ...

In addition to pharmaceuticals, Trump has also called for Section 232 investigations of semiconductors and critical minerals.

Get all latest & breaking news on Pharma Sector. Watch videos, top stories and articles on Pharma Sector at moneycontrol.com.